1. Home
  2. PSTV vs MTEX Comparison

PSTV vs MTEX Comparison

Compare PSTV & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • MTEX
  • Stock Information
  • Founded
  • PSTV 1996
  • MTEX 1993
  • Country
  • PSTV United States
  • MTEX United States
  • Employees
  • PSTV N/A
  • MTEX N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • MTEX Medicinal Chemicals and Botanical Products
  • Sector
  • PSTV Health Care
  • MTEX Health Care
  • Exchange
  • PSTV Nasdaq
  • MTEX Nasdaq
  • Market Cap
  • PSTV 17.0M
  • MTEX 15.8M
  • IPO Year
  • PSTV N/A
  • MTEX 1999
  • Fundamental
  • Price
  • PSTV $0.45
  • MTEX $9.27
  • Analyst Decision
  • PSTV Strong Buy
  • MTEX
  • Analyst Count
  • PSTV 4
  • MTEX 0
  • Target Price
  • PSTV $7.88
  • MTEX N/A
  • AVG Volume (30 Days)
  • PSTV 8.4M
  • MTEX 13.7K
  • Earning Date
  • PSTV 08-14-2025
  • MTEX 08-12-2025
  • Dividend Yield
  • PSTV N/A
  • MTEX N/A
  • EPS Growth
  • PSTV N/A
  • MTEX N/A
  • EPS
  • PSTV N/A
  • MTEX N/A
  • Revenue
  • PSTV $5,317,000.00
  • MTEX $112,975,000.00
  • Revenue This Year
  • PSTV $2.95
  • MTEX N/A
  • Revenue Next Year
  • PSTV $7.89
  • MTEX N/A
  • P/E Ratio
  • PSTV N/A
  • MTEX N/A
  • Revenue Growth
  • PSTV N/A
  • MTEX N/A
  • 52 Week Low
  • PSTV $0.16
  • MTEX $7.05
  • 52 Week High
  • PSTV $2.31
  • MTEX $16.49
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 43.79
  • MTEX 53.85
  • Support Level
  • PSTV $0.39
  • MTEX $8.21
  • Resistance Level
  • PSTV $0.54
  • MTEX $9.18
  • Average True Range (ATR)
  • PSTV 0.05
  • MTEX 0.63
  • MACD
  • PSTV -0.02
  • MTEX 0.07
  • Stochastic Oscillator
  • PSTV 22.96
  • MTEX 51.84

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

Share on Social Networks: